Market Research Logo

Kazakhstan Pharmaceuticals and Healthcare Report Q2 2016

Kazakhstan Pharmaceuticals and Healthcare Report Q2 2016

BMI View: The establishment of a national health insurance fund will markedly boost sales ofpharmaceuticals in Kazakhstan. A reliance on foreign pharmaceutical imports, the population's increasingaccess to healthcare and the government's long-term vision to become a top developed country will seeattractive revenue earning opportunities presented to multinational drugmakers. However, lower thanexpected real GDP growth for 2016 to 2020 due to low oil prices and tenge devaluation affectingpurchasing power will dampen market growth in the short term.

Headline Expenditure Projections

Pharmaceuticals: KZT350bn (USD1.57bn) in 2015 to KZT382bn (USD1.15bn) in 2016; +9.3% in localcurrency terms and -26.8% in US dollar terms. Forecast revised downwards from last quarter.

Healthcare: KZT2.05trn (USD9.19bn) in 2015 to KZT2.34trn (USD7.04bn) in 2016; +14.5% in localcurrency terms and -23.3% in US dollar terms. Forecast revised downwards from last quarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Kazakhstan 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Kazakhstan 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2012-2020)
Prescription Drug Market
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Kazakhstan 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Kazakhstan 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Kazakhstan 2014-2020)
Industry Risk/Reward Index
Central And Eastern Europe Risk/Reward Index
Kazakhstan Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing And Reimbursement Regime
Market Overview
Healthcare Sector
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Chimpharm
Romat
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Kazakhstan 1990-2025)
Table: Key Population Ratios (Kazakhstan 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Kazakhstan 1990-2025)
Table: Population By Age Group (Kazakhstan 1990-2025)
Table: Population By Age Group % (Kazakhstan 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report